Dr. William W Oneill MD

Recommended Articles

• Laryngitis: What Is Croup?

  What is laryngitis?Laryngitis is the swelling of your voice box. It is often caused by an infection, mostly by a virus. The voice box is also known as the larynx. It links the back of your throat to the windpipe. The vocal cord and larynx are part and parcel and are required for speech. Laryngitis...

• Radiologists Look for Patterns in Cystic Fibrosis as More Adults Are Diagnosed

  Recent research shows that there is an increasing number of adults being diagnosed with cystic fibrosis. This information is leading scientists to believe cystic fibrosis is now just as much of an adult condition as a childhood condition. This increase has caused scientists and radiologists to...

• Cystic Fibrosis: A Day in the Life

  Everyday tasks like walking up a set of stairs can be a daunting and debilitating endeavor for individuals with cystic fibrosis. The progressive, lifelong illness causes thick mucus to build up on the inside of critical organs, most notably the lungs. People who live with cystic fibrosis are...

• Is Bronchitis Contagious?

  Is bronchitis contagious? In most cases, only acute bronchitis is contagious. Learn more about when bronchitis is contagious, and how to prevent it from spreading.What is bronchitis?Tubes made of glandular goblet cells that direct air into your lungs, also known as bronchi, are located below the...

• Kids with Cystic Fibrosis Given a “Breath of Life”

  In 1999, Charles Dunlop founded Ambry Genetics because he wanted to work for an organization dedicated to restoring the balance between open science and commercial interests. An organization driven by scientists, genetic counselors, and physicians whose mission would be to put an end to disease and...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...